HHS eliminates CDC staff who made sure birth control is safe for women at risk
The Texas mother of two was diagnosed with a rare and potentially fatal heart condition after having her second child. In addition to avoiding another pregnancy that could be life-threatening, Henderson has to make sure the contraception she uses doesn't jeopardize her health.
For more than a decade, a small team of people at the Centers for Disease Control and Prevention worked to do just that, issuing national guidelines for clinicians on how to prescribe contraception safely for millions of women with underlying medical conditions - including heart disease, lupus, sickle cell disease, and obesity. But the Department of Health and Human Services, which oversees the CDC, fired those workers as part of the Trump administration's rapid downsizing of the federal workforce.
It also decimated the CDC's larger Division of Reproductive Health, where the team was housed - a move that clinicians, advocacy groups, and fired workers say will endanger the health of women and their babies.
Clinicians said in interviews that counseling patients about birth control and prescribing it is relatively straightforward. But for women with conditions that put them at higher risk of serious health complications, special care is needed.
"We really were the only source of safety monitoring in this country," said one fired CDC staffer who worked on the guidelines, known as the U.S. Medical Eligibility Criteria for Contraceptive Use, or MEC. "There's no one who can actually do this work." KFF Health News agreed not to name this worker and others who were not authorized to speak to the press and feared retaliation.
The stakes are high for people like Henderson. About six weeks after having her second baby, she said, her heart "was racing."
"I feel like I'm underwater," Henderson said. "I felt like I couldn't breathe." She eventually went to the hospital, where she was told she was "in full-blown heart failure," she said.
Henderson was diagnosed with peripartum cardiomyopathy, an uncommon type of heart failure that can happen toward the end of pregnancy or shortly after giving birth. Risk factors for the condition include being at least 30 years old, being of African descent, high blood pressure, and obesity.
The CDC contraception guidelines say that combined hormonal contraception, which contains both estrogen and progestin to prevent pregnancy, can pose an "unacceptable health risk" for most women with peripartum cardiomyopathy, also known as PPCM. For some women with the diagnosis, a birth control injection commonly known by the brand name Depo-Provera also carries risks that outweigh its benefits, the guidelines show. Progestin-only pills or a birth control implant, inserted into an arm, are the safest.
Henderson said her cardiologist had to greenlight which contraception she could use. She uses a progestin-only birth control implant that's more than 99% effective at preventing pregnancy.
"I didn't know that certain things can cause blood clots," Henderson said, "or make your heart failure worse." Heart failure is a leading cause of maternal mortality and morbidity in the U.S., with PPCM accounting for up to 70% of heart failure cases during pregnancy.
Sweeping HHS layoffs in late March and early April gutted the CDC's reproductive health division, upending several programs designed to protect women and infants, three fired workers said.
About two-thirds of the division's roughly 165 employees and contractors were cut, through firings, retirements, or reassignments to other parts of the agency, one worker said.
Among those fired were CDC staffers who carried out the Pregnancy Risk Assessment Monitoring System, a survey established nearly 40 years ago to improve maternal and infant health outcomes by asking detailed questions of women who recently gave birth. The survey was used "to help inform and help reduce the contributing factors that cause maternal mortality and morbidity," a fired worker said, by allowing government workers to examine the medical care people received before and during pregnancy, if any, and other risk factors that may lead to poor maternal and child health.
The firings also removed CDC workers who collected and analyzed data on in vitro fertilization and other fertility treatments.
"They left nothing behind," one worker said.
U.S. contraception guidelines were first published in 2010, after the CDC adapted guidance developed by the World Health Organization. The latest version was published last August. It includes information about the safety of different types of contraception for more than 60 medical conditions. Clinicians said it is the premier source of evidence about the safety of birth control.
"It gave us so much information which was not available to clinicians at their fingertips," said Michael Policar, a physician and professor of obstetrics, gynecology, and reproductive sciences at the University of California-San Francisco School of Medicine.
"If you've got a person with, let's say, long-standing Type 2 diabetes, someone who has a connective-tissue disease like lupus, someone who's got hypertension or maybe has been treated for a precursor to breast cancer - something like that? In those circumstances," Policar said, "before the MEC it was really hard to know how to manage those people."
The CDC updates the guidelines comprehensively roughly every five years. On a weekly basis, however, government workers would monitor evidence about patients' use of contraception and the safety of various methods, something they were doing when HHS abruptly fired them this spring, two fired workers said. That work isn't happening now, one of them said.
Sometimes the agency would issue interim changes outside the larger updates if new evidence warranted it. Now, if something new or urgent comes up, "there's not going to be any way to update the guidelines," one fired worker said.
In 2020, for example, the CDC revised its contraception recommendations for women at high risk of HIV infection, after new evidence showed that various methods were safer than previously thought.
HHS spokesperson Emily Hilliard declined to say why CDC personnel working on the contraception guidelines and other reproductive health issues were fired, or answer other questions raised by KFF Health News' reporting.
Most women of reproductive age in the U.S. use contraception. CDC data from 2019, the most recent available, shows that more than 47 million women ages 15 to 49 relied on birth control. About 1 in 10 used long-acting methods such as intrauterine devices and implants; 1 in 7 used oral contraception.
The latest guidelines included updated safety recommendations for women who have sickle cell disease, lupus, or PPCM, and those who are breastfeeding, among others. Clinicians are now being told that combined hormonal contraception poses an unacceptable health risk for women with sickle cell disease, because it might increase the risk of blood clots.
"It can really come down to life or death," said Teonna Woolford, CEO of the Sickle Cell Reproductive Health Education Directive, a nonprofit that advocates for improved reproductive health care for people with the disease.
"We really saw the CDC guidelines as a win, as a victory - they're actually going to pay attention," she said.
The 2024 guidelines also for the first time included birth control recommendations for women with chronic kidney disease. Research has shown that such women are at higher risk of serious pregnancy complications, including preeclampsia and preterm delivery. Their medical condition also increases their risk of blood clots, which is why it's important for them not to use combined hormonal contraception, fired CDC workers and clinicians said.
The CDC information "is the final say in safety," said Patty Cason, a family nurse practitioner and president of Envision Sexual and Reproductive Health. Having only static information about the safety of various types of birth control is "very scary," she said, because new evidence could come out and entirely new methods of contraception are being developed.
Henderson said it took her heart two years to recover. She created the nonprofit organization Let's Talk PPCM to educate women about the type of heart failure she was diagnosed with, including what forms of birth control are safe.
"We don't want blood clots, worsening heart failures," Henderson said. "They already feel like they can't trust their doctors, and we don't need extra."
____
Copyright (C) 2025, Tribune Content Agency, LLC. Portions copyrighted by the respective providers.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New York Times
3 hours ago
- New York Times
‘I Never Want to See a Case of Polio, but I'm Very Fearful I Will'
Pediatricians like me come to our job with the conviction that children should not die — that whatever might hurt or kill them should be prevented, whether through car seat laws, safety tops on medication bottles, pediatric cancer research or, above all, routine vaccination. Now we're worried that vaccination will become less routine and less available. That the health care structure that keeps children safe may be under threat. That we will watch children suffer and even die, watch families grieve — and that part of the horror will be knowing that these were preventable diseases. The Centers for Disease Control and Prevention's vaccine advisory group met last week — its first meeting since the health secretary, Robert F. Kennedy Jr., dismissed the panel's 17 experts and installed eight handpicked replacements, several with histories of vaccine skepticism. There, the panel, down to seven members after one withdrew, announced a review of the entire childhood vaccine schedule. That's scary. The recommendations of the panel, the Advisory Committee on Immunization Practices, help determine what vaccines are provided at no cost for about half of American children through the Vaccines for Children Program and influence coverage by private insurers. If the committee turns science-based recommendations into wishy-washy talk-to-your-doctor suggestions or, worse, takes certain vaccines off the schedule, America risks unraveling the infrastructure that keeps children vaccinated and without polio, diphtheria, whooping cough, tetanus, measles, mumps, rubella, bacterial meningitis and all the other horrors. 'Every day I have at least one parent ask me, 'Are you still going to be able to give vaccines? Can I do something now in case they're not available later?'' said my colleague Dr. Jane Guttenberg, a pediatrician in New York City. Can we imagine a two-tiered system in which protection is available only to those with the means to pay hundreds of dollars for a vaccination? Can we imagine not giving a vaccine that a child needs? 'I've been thinking about that a lot,' said Dr. Sally Goza, a primary care pediatrician in suburban Georgia. 'Vaccines cost us money. I can't just give vaccines away. I wish I could.' Want all of The Times? Subscribe.


Time Business News
7 hours ago
- Time Business News
Breathe Better, Look Sharper: Why Dubai is a Top Destination for Rhinoplasty
Rhinoplasty, commonly known as a nose job, is one of the most sought-after cosmetic surgeries worldwide. Whether it's for enhancing facial harmony or correcting breathing problems, rhinoplasty has the power to transform not only how you look, but also how you feel. In recent years, Dubai has become a leading hub for rhinoplasty, attracting both local residents and international patients. But what makes rhinoplasty in Dubai such a popular choice? Let's explore why people are flying to Dubai for this life-enhancing procedure and what you should expect from it. Rhinoplasty is a surgical procedure aimed at reshaping the nose. It can involve: Making the nose smaller or larger Changing the shape of the bridge, tip, or nostrils Fixing breathing issues due to structural problems like a deviated septum Repairing injuries or congenital defects The goal is to create a natural, balanced appearance while maintaining or improving nasal function. Dubai isn't just known for its skyscrapers and luxury shopping — it's also home to some of the world's most advanced medical facilities. Here's why rhinoplasty in Dubai is a top choice: Dubai attracts highly qualified plastic surgeons from around the globe. Many are certified by international boards and have trained in top medical institutions. These professionals have extensive experience in both cosmetic and reconstructive rhinoplasty. Clinics in Dubai offer modern technology and equipment that meet international standards. This ensures safer procedures, faster recovery, and better results. 3D imaging and simulation software allow you to preview your potential outcome before surgery. Dubai's diverse population means that surgeons here have experience working with all types of noses — from Middle Eastern to Asian, African, and Caucasian profiles. This expertise helps achieve more natural-looking results that suit each individual's unique facial features. Many clinics in Dubai are designed to feel more like luxury hotels than hospitals. With private recovery suites, concierge services, and a discreet environment, patients can undergo treatment and recovery with complete peace of mind. Dubai's efficient visa process, excellent transport links, and top-tier hospitality services make it ideal for medical tourists. Many clinics even offer packages that include accommodation, airport pickup, and follow-up appointments. Your journey begins with a detailed consultation. The surgeon will assess your nasal structure, discuss your goals, and explain the risks and benefits. You may undergo imaging scans and be asked to stop smoking or taking certain medications before surgery. The surgery usually takes 1–3 hours and can be done under general or local anesthesia. Depending on the case, your surgeon may use an 'open' or 'closed' technique. You'll go home the same day or after one night in the clinic. Recovery time varies from person to person. Swelling and bruising are common for the first week, but most patients can return to normal activities within 7–10 days. Full healing and final results may take several months. If you are unhappy with the appearance of your nose or suffer from breathing issues, rhinoplasty might be the solution. However, it's important to have realistic expectations and be in good overall health. An experienced surgeon will help you decide whether surgery is appropriate for you. Prices vary depending on the clinic, surgeon's experience, and complexity of the procedure. On average, rhinoplasty in Dubai ranges from AED 18,000 to AED 35,000. While this might seem expensive, the high level of care and expertise makes it worth the investment. If you're considering this procedure, take time to choose the right clinic. A good starting point is this trusted provider offering rhinoplasty in Dubai. Rhinoplasty can be a life-changing decision — one that improves your looks, boosts your confidence, and enhances your quality of life. With Dubai's skilled surgeons, luxurious care, and global reputation, it's easy to see why so many people are choosing this city for their transformation journey. Whether you're looking for subtle refinement or a significant change, Dubai offers the expertise and environment to help you achieve your ideal results. TIME BUSINESS NEWS
Yahoo
7 hours ago
- Yahoo
Trump officials ‘secretly' changed US health data in ‘gender ideology' crackdown, researchers allege
The Trump administration quietly altered massive US health datasets to remove any mention of gender, according to a new analysis. Scientists around the world rely on health data from US government agencies like the Centers for Disease Control and Prevention (CDC). But since President Donald Trump took office in January, these agencies have been altering data labels, mostly without disclosure, according to the investigation published in The Lancet, a leading medical journal. The authors argue that the 'hidden' changes could cast doubt on the integrity of American science. The database edits 'might be politically motivated and [are] not transparent,' Dr Aaron Kesselheim, a professor at Harvard Medical School, and Janet Freilich, a law professor at Boston University, said in the paper. Related Will Trump's funding cuts help Europe lure top research talent from the US? Their analysis included 232 US health datasets that were edited from late January to late March, covering veterans' health care use, global tobacco consumption, stroke deaths, nutrition, exercise, and obesity. It did not include datasets that are updated on a regular basis. About half of these datasets were 'substantially altered' during the two-month period, but only 15 acknowledged that changes had been made, the study found. The parts of the datasets meant for these disclosures remained empty as of early May, the researchers said. In most of the edited datasets – 106 of them – the word 'gender' was swapped out for 'sex'. Related US demands that EU companies comply with anti-diversity order US agencies have not confirmed or explained the changes, but Freilich and Kesselheim suspect they were made to comply with a Trump order to remove 'messages that promote or otherwise inculcate gender ideology'. The executive order, issued on Trump's first day in office, said it aimed to restore 'biological truth' to US agencies, and set a national policy 'to recognise two sexes, male and female,' they said. It was part of a flurry of activity to clamp down on LGBTQ protections. Some data was initially removed from federal websites, but was largely restored due to a court order. Related Trump administration's funding freeze for foreign medical research to hit European scientists The Lancet analysis indicates that not all changes were reversed. It is not clear if the actual numbers were altered, or only the labels about gender or sex. But Freilich and Kesselheim said the distinction is important because some people will respond to surveys differently based on each term. That can undermine the quality of the data and lead researchers to draw inaccurate conclusions, they said. They described the undisclosed changes as a 'crisis' that could make US data 'untrustworthy and unusable'. They called on governments elsewhere in the world to invest in other data sources.